英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
AER-271 |
AER-271 |
634913-39-6 |
詳細(xì)
|
6-bromo-1-chloro-7-methoxyIsoquinoline |
6-溴-1-氯-7-甲氧基異喹啉 |
758710-74-6 |
詳細(xì)
|
GSK-2894631A |
GSK-2894631A |
2101626-26-8 |
詳細(xì)
|
BENZAMIDE, N-[3-[[2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-1H-IMIDAZO[4,5-C]PYRIDIN-6-YL]OXY]PHENYL]-4-[2-(4-MORPHOLINYL)ETHOXY]- |
BENZAMIDE, N-[3-[[2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-1H-IMIDAZO[4,5-C]PYRIDIN-6-YL]OXY]PHENYL]-4-[2-(4-MORPHOLINYL)ETHOXY]- |
925213-63-4 |
詳細(xì)
|
ML365 |
ML-365 |
947914-18-3 |
詳細(xì)
|
N-[[4-(2,2-dicyano-1-methoxy-vinyl)phenyl]methyl]-5-fluoro-2-methoxy-benzamide |
N-[[4-(2,2-二氰基-1-甲氧基-乙烯基)苯基]甲基]-5-氟-2-甲氧基苯甲酰胺 |
2764851-04-7 |
詳細(xì)
|
Dimethylsulfoximine |
二甲基亞磺酰亞胺 |
1520-31-6 |
詳細(xì)
|
AWZ1066S |
AWZ1066S |
2239272-16-1 |
詳細(xì)
|
Benzoic acid, 4-[[(5-fluoro-2-methoxybenzoyl)amino]methyl]-, methyl ester |
|
2182032-85-3 |
詳細(xì)
|
Carbamic acid, N-[(1S,2R)-1-ethyl-2-hydroxypropyl]-, 1,1-dimethylethyl ester |
Carbamic acid, N-[(1S,2R)-1-ethyl-2-hydroxypropyl]-, 1,1-dimethylethyl ester |
1354227-36-3 |
詳細(xì)
|
ethyl 5-aMino-1-(2-fluorobenzyl)-1H-pyrazole-3-carboxylate |
5-氨基-1-(2-氟芐基)-1H-吡唑-3-羧酸乙酯 |
256504-39-9 |
詳細(xì)
|
Propanedinitrile, 2-[(4-bromophenyl)methoxymethylene]- |
2-[(4-溴苯基)-甲氧基亞甲基]丙二腈 |
1188083-45-5 |
詳細(xì)
|
2-Pyridinamine, 6-chloro-4-methyl-5-(trifluoromethyl)- |
6-氯-4-甲基-5-(三氟甲基)吡啶-2-胺 |
2417920-99-9 |
詳細(xì)
|
LUT-014 |
LUT-014 |
2274819-46-2 |
詳細(xì)
|
6-chloro-2-methyl-2H-indazol-5-amine |
6-氯-2-甲基-2H-吲唑-5-胺 |
1893125-36-4 |
詳細(xì)
|
7-methoxyisoquinoline-6-carbonitrile(WX130309) |
7-methoxyisoquinoline-6-carbonitrile(WX130309) |
1817630-36-6 |
詳細(xì)
|
MK-3903 |
MK-3903 |
1219737-12-8 |
詳細(xì)
|
NIBR189 |
NIBR189 |
1599432-08-2 |
詳細(xì)
|
GSK3145095 |
GSK3145095 |
1622849-43-7 |
詳細(xì)
|
Lesinurad Impurity B |
雷西納德雜質(zhì)B |
1533519-93-5 |
詳細(xì)
|
CZC-25146 |
CZC25146 |
1191911-26-8 |
詳細(xì)
|
LJ570 |
LJ570 |
2252488-69-8 |
詳細(xì)
|
Lesinurad Impurity 5 Sodium Salt |
雷西納德雜質(zhì)M |
1384208-36-9 |
詳細(xì)
|
Denfivontinib |
G-749 |
1457983-28-6 |
詳細(xì)
|
(7R,7aS)-7-ethyl-3,3-dimethyltetrahydro-3H,5H-pyrrolo[1,2-c]oxazol-5-one |
(7R,7AS)-7-乙基-3,3-二甲基-六氫吡咯并[1,2-C][1,3]噁唑-5-酮 |
1817631-47-2 |
詳細(xì)
|
2-(Hydroxymethyl)-2-(methoxymethyl)-1-azabicyclo[2.2.2]octan-3-one |
APR-246 |
5291-32-7 |
詳細(xì)
|
DSP-2230 |
DSP-2230 |
1233231-30-5 |
詳細(xì)
|
GSK547 |
GSK547 |
2226735-55-1 |
詳細(xì)
|
7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-amine |
7-甲基-[1,2,4]三唑并[1,5-A]吡啶-6-胺 |
2172466-50-9 |
詳細(xì)
|
Riociguat |
利奧西呱 |
625115-55-1 |
詳細(xì)
|
Verinurad |
維立諾雷 |
1352792-74-5 |
詳細(xì)
|
(2R,3S)-3-AMINO-PENTAN-2-OL |
(2R,3S)-3-AMINO-PENTAN-2-OL |
482615-48-5 |
詳細(xì)
|
3-[4-Hydroxy-3-[5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-(pentyloxy)-2-naphthalenyl]phenyl]-2-propenoicacid |
UVI 3003 |
847239-17-2 |
詳細(xì)
|
KL1333 |
KL1333 |
1800405-30-4 |
詳細(xì)
|
SPASTAZOLINE |
SPASTAZOLINE |
2351882-11-4 |
詳細(xì)
|
Benzoic acid, 4-[[(5-fluoro-2-methoxybenzoyl)amino]methyl]- |
4-[[(5-氟-2-甲氧基苯甲?;?氨基]甲基]苯甲酸 |
1571888-11-3 |
詳細(xì)
|
1-CHLORO-7-METHOXYISOQUINOLINE-6-CARBONITRILE(WX130310) |
1-氯-7-甲氧基異喹啉-6-甲腈 |
1427393-40-5 |
詳細(xì)
|
RK-287107 |
RK-287107 |
2171386-10-8 |
詳細(xì)
|
GSK6853 |
GSK6853 |
1910124-24-1 |
詳細(xì)
|
(8R,9S)-Talazoparib |
(8R,9S)-5-氟-8-(4-氟苯基)-2,7,8,9-四氫-9-(1-甲基-1H-1,2,4-三唑-5-基)-3H-吡啶并[4,3,2-DE]酞嗪-3-酮 |
1207456-00-5 |
詳細(xì)
|
1-NM-PP1 |
1 NM-PP1 |
221244-14-0 |
詳細(xì)
|
Benzamide, N-[[4-[5-amino-4-cyano-1-(2,2,2-trifluoro-1-methylethyl)-1H-pyrazol-3-yl]phenyl]methyl]-5-fluoro-2-methoxy- |
N-(4-(5-AMINO-4-CYANO-1-(1,1,1-TRIFLUOROPROPAN-2-YL)-1H-PYRAZOL-3-YL)BENZYL)-5-FLUORO-2-METHOXYBENZA |
2101703-40-4 |
詳細(xì)
|
2-(1,2-dihydroxyethyl)-5-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)tetrahydrofuran-3,4-diol |
卡格列凈雜質(zhì)6 |
211533-80-5 |
詳細(xì)
|
tert-butyl (4-bromothiophen-3-yl)carbamate |
(4-溴噻吩-3-基)氨基甲酸叔丁酯 |
119485-57-3 |
詳細(xì)
|
BMN 673 |
1207454-56-5 |
1207454-56-5 |
詳細(xì)
|
1H-Pyrazole-4-carbonitrile, 5-amino-3-(4-bromophenyl)-1-(2,2,2-trifluoro-1-methylethyl)- |
|
2101703-39-1 |
詳細(xì)
|
(S)-3,3-dimethyl-1,7a-dihydro-3H,5H-pyrrolo[1,2-c]oxazol-5-one |
PF-06416498 |
203871-49-2 |
詳細(xì)
|
Canagliflozin-10 |
卡格列凈雜質(zhì)11 |
2161394-94-9 |
詳細(xì)
|
Cagliar Net Impurity 10 |
卡格列凈雜質(zhì)10 |
2268660-58-6 |
詳細(xì)
|
Canagliflozin Impurity 14 |
卡格列凈雜質(zhì)14 |
028977-37-8 |
詳細(xì)
|
Cagliflozin impurity 9 |
Cagliflozin impurity 9 |
1956355-91-1 |
詳細(xì)
|
Canagliflozin α Isomer |
卡格列凈異構(gòu)體 |
1589590-87-3 |
詳細(xì)
|
6-chloro-2,3-dimethyl-2H-Indazole |
|
1426675-40-2 |
詳細(xì)
|
incb057643 |
incb057643 |
1820889-23-3 |
詳細(xì)
|
BAY-545 |
BAY-545 |
1699717-32-2 |
詳細(xì)
|
Cilofexor |
CILOFEXOR; GS-9674; GS 9674; GS9674; |
1418274-28-8 |
詳細(xì)
|
1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile |
1-[(2-氟苯基)甲基] -1H-吡唑并[3,4-b]吡啶-3-甲腈 |
256376-65-5 |
詳細(xì)
|
PD-126055 free acid |
EMA401 |
1316755-16-4 |
詳細(xì)
|
EMA400 |
EMA400 |
152362-51-1 |
詳細(xì)
|
(3S,4S,5S)-4-ethyl-3-fluoro-5-(hydroxymethyl)pyrrolidin-2-one |
(3S,4S,5S)-4-ethyl-3-fluoro-5-(hydroxymethyl)pyrrolidin-2-one |
1817630-30-0 |
詳細(xì)
|
4,6-DIAMINO-2-METHYL-QUINOLINE |
2-甲基喹啉-4,6-二胺 |
5443-31-2 |
詳細(xì)
|
Cyclopropanemethanol, 1-(1-pyrrolidinyl)- (9CI) |
(1-(PYRROLIDIN-1-YL)CYCLOPROPYL)METHANOL |
387845-17-2 |
詳細(xì)
|
2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline |
2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯胺 |
1609394-10-6 |
詳細(xì)
|
2-amino-6-fluoropyrazolo[1,5-a]pyrimidine-3-carboxylicacid |
2-氨基-6-氟吡唑并[1,5-A]嘧啶-3-羧酸 |
1613191-77-7 |
詳細(xì)
|
AM-2394 |
AM2394 |
1442684-77-6 |
詳細(xì)
|
Navoximod |
1402837-78-8 |
1402837-78-8 |
詳細(xì)
|
(3-exo)-8-Methyl-8-azabicyclo[3.2.1]octane-3-thiol hydrochloride |
外-托品-3-硫醇鹽酸鹽 |
1141886-66-9 |
詳細(xì)
|
Talazoparib |
(8S,9R)-5-氟-8-(4-氟苯基)-2,7,8,9-四氫-9-(1-甲基-1H-1,2,4-三唑-5-基)-3H-吡啶并[4,3,2-DE]酞嗪-3-酮 |
1207456-01-6 |
詳細(xì)
|
2-Pyridinamine, 6-bromo-N,N-bis[(4-methoxyphenyl)methyl]-4-methyl-5-(trifluoromethyl)- |
6-BROMO-N,N-BIS(4-METHOXYBENZYL)-4-METHYL-5-(TRIFLUOROMETHYL)PYRIDIN-2-AMINE |
2411793-14-9 |
詳細(xì)
|
(3R,4S,5R,6R)-6-(acetoxyMethyl)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triyl |
(3R,4S,5R,6R)-6-(乙酰氧基甲基)-2-(3 - ((5-(4-氟苯基)噻吩-2-基) |
1222075-02-6 |
詳細(xì)
|
(3R,4S,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol |
卡格列凈雜質(zhì)2 |
1818268-44-8 |
詳細(xì)
|
2-(5-broMo-2-Methylbenzyl)-5-phenylthiophene |
卡格列凈雜質(zhì)3 |
200545-69-1 |
詳細(xì)
|
Ruxolitinib |
魯索替尼 |
941678-49-5 |
詳細(xì)
|
6H,15H-Dibenzo[b,i][1,4,8,11]tetraoxacyclotetradecin, 7,8,16,17-tetrahydro- |
|
14174-06-2 |
詳細(xì)
|
Loganin |
馬錢子苷 |
18524-94-2 |
詳細(xì)
|
Morroniside |
莫諾苷 |
25406-64-8 |
詳細(xì)
|
Astragaloside-Ⅱ |
黃芪皂苷 II |
84676-89-1 |
詳細(xì)
|
Dihydroberberine |
二氫小檗堿 |
483-15-8 |
詳細(xì)
|
(±)-Enitociclib |
1610358-53-6 |
1610358-53-6 |
詳細(xì)
|
Ginsenoside Re |
人參皂甙RE |
51542-56-4 |
詳細(xì)
|
Astragaloside I |
黃芪皂苷 I |
84680-75-1 |
詳細(xì)
|
Vinblastine sulfate |
硫酸長春堿 |
143-67-9 |
詳細(xì)
|
2-(3-hydroxyphenyl)-N-(5-methyl-4-(1-(2-methylbenzoyl)indolin-5-yl)thiazol-2-yl)acetamide |
|
1628465-87-1 |
詳細(xì)
|
(E)-methyl 3-(3,5-difluoro-4-formylphenyl)acrylate |
(E)-3-(3,5-二氟-4-甲酰基苯基)丙烯酸甲酯 |
1639042-39-9 |
詳細(xì)
|
loganic acid |
馬錢苷酸 |
22255-40-9 |
詳細(xì)
|
Harpagoside |
哈巴俄苷 |
19210-12-9 |
詳細(xì)
|
Ajugol |
益母草苷A |
52949-83-4 |
詳細(xì)
|
Lesinurad Impurity L |
Lesinurad Impurity L |
1158970-49-0 |
詳細(xì)
|
Gentiopicroside |
龍膽苦苷 |
20831-76-9 |
詳細(xì)
|
(1-(2,2,2-trifluoroethyl)-1H-pyrazol-5-yl) |
(1-(2,2,2-三氟乙基)-1H-吡唑-5-基)甲醇 |
1296225-26-7 |
詳細(xì)
|
echinacoside |
松果菊苷 |
82854-37-3 |
詳細(xì)
|
1-(2-(2-chloro-3-methyl-4-(4,4,5,5-tetramethyl |
2-甲基-3-氯-4-[2-(4-甲基-1-哌嗪基)乙氧基]苯硼酸頻哪醇酯 |
1799612-11-5 |
詳細(xì)
|
netoginsenoside R1 |
三七皂苷 R1 |
80418-24-2 |
詳細(xì)
|
corilagin |
柯里拉京 |
23094-69-1 |
詳細(xì)
|
Catharanthine |
長春質(zhì)堿 |
2468-21-5 |
詳細(xì)
|
n-Propyl Dioxepin |
正丙基七環(huán) |
4469-34-5 |
詳細(xì)
|
Berberine |
黃蓮素 |
2086-83-1 |
詳細(xì)
|
Lesinurad Impurity A |
雷西納德雜質(zhì)A |
1533519-98-0 |
詳細(xì)
|
Lesinurad Impurity 2 |
Lesinurad Impurity 2 |
1158970-37-6 |
詳細(xì)
|
Tetrahydroberberine |
四氫小檗堿 |
522-97-4 |
詳細(xì)
|